https://biotechmorning.com/news/kennedy-hhs-vaccine-policy-document-details Biotech Morning en 2026-08-22T14:18:26.359Z Inside Kennedy's Vaccine Playbook: What a Leaked HHS Document Tells Us https://biotechmorning.com/news/polish-company-matched-ozempic-novo-nordisk Biotech Morning en 2026-08-22T14:17:43.868Z A Polish Company Just Matched Ozempic. Novo Nordisk Should Be Nervous. https://biotechmorning.com/news/capricor-duchenne-fda-rejection-activist-investor Biotech Morning en 2026-08-22T14:17:02.271Z Capricor's Duchenne Drug Just Hit a Wall. Then the Activist Investors Showed Up. https://biotechmorning.com/news/supernus-indivior-cns-merger-2 Biotech Morning en 2026-08-22T14:16:08.960Z Two Mid-Cap Pharma Companies Just Bet They're Better Together https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-job-cuts Biotech Morning en 2026-08-22T14:15:24.796Z Sarepta's $900M Drug Just Got the FDA's Scariest Label https://biotechmorning.com/news/sentynl-mereo-475m-rare-lung-disease-deal Biotech Morning en 2026-08-22T14:14:37.008Z The $475M Bet on a Lung Disease Most Doctors Miss https://biotechmorning.com/news/werewolf-therapeutics-ambros-reverse-merger-painkiller Biotech Morning en 2026-08-22T14:13:48.599Z A Werewolf Just Became a Painkiller Company https://biotechmorning.com/news/sandoz-henlius-322-million-biosimilar-deal Biotech Morning en 2026-08-22T14:13:00.699Z Sandoz Just Went Shopping in Shanghai for $322 Million https://biotechmorning.com/news/4-1bb-first-drug-filing-leads-biolabs Biotech Morning en 2026-08-22T14:12:17.970Z The Target Big Pharma Couldn't Crack Just Got Its First Drug Filing https://biotechmorning.com/news/resilience-cdmo-bankruptcy-six-sites-closing Biotech Morning en 2026-08-22T14:11:28.453Z The $2 Billion Biotech Factory That's Shutting Half Its Lights Off https://biotechmorning.com/news/blood-test-alzheimers-replaces-pet-scan Biotech Morning en 2026-08-21T14:14:34.724Z A $200 Blood Draw Could Replace a $3,000 Brain Scan for Alzheimer's https://biotechmorning.com/news/boehringer-mystery-safety-scare-japan Biotech Morning en 2026-08-21T14:13:41.460Z Boehringer's Mystery Safety Scare in Japan https://biotechmorning.com/news/roche-750-million-oregon-biologics-manufacturing Biotech Morning en 2026-08-21T14:12:55.392Z Roche Just Bet $750 Million That Oregon Is the Future of Drug Manufacturing https://biotechmorning.com/news/teva-appeals-court-ira-drug-pricing-challenge Biotech Morning en 2026-08-21T14:12:11.706Z Teva Just Cracked Open a Door Big Pharma Thought Was Locked https://biotechmorning.com/news/149-pill-blow-up-glp1-war Biotech Morning en 2026-08-21T14:11:25.731Z The $149 Pill That Could Blow Up the GLP-1 War https://biotechmorning.com/news/ultragenyx-gsd-ia-gene-therapy-fda-approval Biotech Morning en 2026-08-21T14:10:38.875Z The $2.7 Million Shot That Replaces a Lifetime of Eating Cornstarch https://biotechmorning.com/news/biontech-two-drug-cocktail-lung-cancer Biotech Morning en 2026-08-21T14:09:53.889Z BioNTech's Two-Drug Cocktail Nobody Has Tried in Lung Cancer https://biotechmorning.com/news/bms-chai-discovery-ai-antibody-deal Biotech Morning en 2026-08-21T14:09:06.644Z BMS Just Hired a Robot to Design Its Next Blockbuster Antibody https://biotechmorning.com/news/amgen-walks-away-tscan-tcr-therapy-deal Biotech Morning en 2026-08-21T14:08:19.139Z Amgen Just Walked Away From a Half-Billion-Dollar Bet on T-Cell Therapy